Multiple positive catalysts lifted pharmaceutical stocks, with institutional analysts confirming a right-side reversal in the CXO sector's sentiment.

Biotech stocks listed in Hong Kong extended their gains. As of the time of writing, Pregene Biopharma surged over 38%, Joinn Laboratories rose more than 15%, Biointron climbed nearly 14%, Duality Biologics gained over 11%, PharmAgra Labs advanced over 8%, and Tigermed increased by nearly 8%.

cls.cn11:12

WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy

PR NewswireJul 9 15:31

Hong Kong Market Midday Commentary | Hang Seng Index Down 0.78% in Morning Session; Semiconductors Rise Against the Trend

Most semiconductor stocks rose. Changxin Technology's IPO is imminent, as strong domestic computing power demand gradually materializes.

Zhitong FinanceJul 9 12:00

Hong Kong Stock Market Update | Wuxi Bio (2269.HK) rises over 6% in early trading as its MFG8 drug substance manufacturing facility passes the U.S. FDA pre-approval inspection

Wuxi Bio (02269) rose more than 6% in early trading. As of the time of writing, it was up 4.6% at HK$37.3, with a trading volume of HK$445 million.

Zhitong FinanceJul 9 10:13

Express News | Wuxi Bio's MFG8 Drug Substance Manufacturing Facility Passes U.S. FDA Pre-License Inspection

BreakingsJul 9 09:13

WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year

PR NewswireJul 8 15:15